Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.